News | May 18, 2015

Focal Therapy Program Expands at Mount Sinai for Prostate Cancer Treatment

Health system brings in renowned focal therapy expert to lead multidisciplinary treatment efforts, instruct others on fusion-guided biopsies

Mount Sinai, focal therapy, prostate cancer, Rastinehad, fusion-guided biopsy

May 18, 2015 — Mount Sinai (New York) is expanding its use of an image-guided technology that focuses on removing only cancerous tissue in the prostate, sparing the rest of the gland. The technique presents a contrast to traditional approaches, where removing the entire prostate leaves patients safe from cancer, but facing profound sexual and urinary side effects.  

Focal therapy is a technique of treating only the cancerous areas of the prostate, not affecting the rest of the prostate. The focal therapy program at Mount Sinai will be the first to use fusion biopsy technology to deliver treatment more precisely. Fusion-guided biopsy, an imaging technique which combines magnetic resonance (MRI) and ultrasound imaging to better visualize the prostate during procedures, has been in use at Mount Sinai since 2013 for obtaining biopsy samples.

The newly expanded program will be led by Art R. Rastinehad, DO, director of focal therapy and interventional urologic oncology and associate professor of urology and radiology at the Icahn School of Medicine at Mount Sinai. Rastinehad, who joined Mount Sinai from the North Shore-LIJ Health System in January, is a recognized leader in the design of the imaging and the screening techniques at the foundation of focal therapy. In collaboration with the National Cancer Institute and Philips Health care, for instance, he helped to develop the first fusion biopsy device.

Rastinehad is the first dual fellowship trained urological oncologist to practice interventional urology. In his new position, he will work with other industry leaders at the Icahn School of Medicine at Mount Sinai to advance a multidisciplinary approach to treating prostate cancer.

Since joining the Mount Sinai Health System, Rastinehad led the first international course on MRI/US fusion-guided biopsies, sponsored by the American Urological Association and hosted at the Icahn School of Medicine at Mount Sinai in December of last year.

For more information: www.mountsinai.org

Related Content

With a wealth of landmark studies in Breast, Cervical, Melanoma, Prostate, Colorectal, Oesophagus, Endocrine and Lung cancer, the ESMO Congress 2021 is a clear demonstration that oncology research has once again gathered momentum after being temporarily stopped in its tracks by the outbreak of the virus

Getty Images

News | Radiation Oncology | September 13, 2021
September 13, 2021 — At the opening press conference of the ...
Comment letters on the 2022 physician fee schedule and Radiation Oncology Model urge CMS to scale back extreme cuts that jeopardize access to life-saving cancer treatments

Getty Images

News | ASTRO | September 09, 2021
September 9, 2021 — The American Society for Radiation Oncology (AS...
Cedars-Sinai Cancer researchers have discovered that intestinal microorganisms help regulate anti-tumor immune responses to radiation treatments.

Getty Images

News | Radiation Therapy | September 01, 2021
September 1, 2021 — The study, published on Aug.
RefleXion Medical, Inc., a therapeutic oncology company pioneering biology-guided radiotherapy (BgRT) as a new modality that will one day treat all stages of cancer,announced the sale of its RefleXion X1 machine to The Center for Cancer and Blood Disorders, a free-standing cancer treatment center with 15 locations throughout northern Texas.

RefleXion Medical announces the sale of its X1 machine to The Center for Cancer and Blood Disorders in Texas. (Photo: Business Wire)

News | Radiation Therapy | August 23, 2021
August 23, 2021 — ...
The global radiotherapy market is forecasted to reach USD 7987.01 Million in the year 2020, according to the "Global Radiotherapy Market - Analysis By Procedure (External Radiation, Internal Radiation), Product, Application, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)" report from ResearchAndMarkets.com
News | Radiation Therapy | August 20, 2021
August 20, 2021 — The global radiotherapy market is forecasted to reach $8.29 billion in the year 2021, according to